rawfin.tv
Bank of America Allocates $250 Million Annually for Employee Weight-Loss Drugs
MarketsstocksAI Generated

Bank of America Allocates $250 Million Annually for Employee Weight-Loss Drugs

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Bank of America is spending $250 million annually to provide weight-loss drugs to its employees, citing positive impacts. This initiative reflects a growing trend among companies offering such benefits to attract and retain talent.

Bank of AmericaEmployee BenefitsHealthcare CostsPharmaceuticalsCorporate Spending

Related Articles